Literature DB >> 6603478

Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

T A Merritt, C G Cochrane, K Holcomb, B Bohl, M Hallman, D Strayer, D K Edwards, L Gluck.   

Abstract

Pulmonary effluent samples were obtained from 26 preterm or term infants throughout the period of endotracheal intubation. Infants with respiratory distress syndrome, infants with this disorder developing bronchopulmonary dysplasia, and intubated infants without lung disease were compared daily in terms of lung effluent cellularity, albumin, elastase activity, alpha 1-proteinase content and activity, and elastase inhibitory capacity. The elastase activity was determined to be neutrophilic in origin. Polyacrylamide gel electrophoresis of pulmonary effluents from two infants with respiratory distress syndrome and exposed to FiO2 greater than or equal to 0.6 up to 6 d revealed cleavage of alpha 1-proteinase inhibitor to a 47,000-mol weight fragment suggestive of oxidation. Pulmonary effluent neutrophils, macrophages, and elastase activity were increased by day 3 of life in infants with respiratory distress syndrome eventually developing bronchopulmonary dysplasia. Elastase inhibitory capacity and alpha 1-proteinase inhibitor activity were reduced in infants developing chronic lung disease. Bronchopulmonary dysplasia developed in infants with enhanced inflammatory response, but with less or inhibited antiprotease activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603478      PMCID: PMC1129225          DOI: 10.1172/JCI111015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

Review 1.  Hyaline membrane disease.

Authors:  P M Farrell; M E Avery
Journal:  Am Rev Respir Dis       Date:  1975-05

2.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants.

Authors:  H Carp; A Janoff
Journal:  Am Rev Respir Dis       Date:  1978-09

3.  Radiographic diagnosis of hyaline membrane disease.

Authors:  S L Wolfson; R Frech; C Hewitt; D R Shanklin
Journal:  Radiology       Date:  1969-08       Impact factor: 11.105

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  Quantity and character of elastin in developing human lung parenchymal tissues of normal infants and infants with respiratory distress syndrome.

Authors:  F W Keeley; D G Fagan; S I Webster
Journal:  J Lab Clin Med       Date:  1977-12

7.  The elastase activity of alveolar macrophages: measurements using synthetic substrates and elastin.

Authors:  E A Levine; R M Senior; J V Butler
Journal:  Am Rev Respir Dis       Date:  1976-01

8.  Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report.

Authors:  R A Ehrenkranz; B W Bonta; R C Ablow; J B Warshaw
Journal:  N Engl J Med       Date:  1978-09-14       Impact factor: 91.245

9.  Bronchopulmonary dysplasia: possible relationship to pulmonary edema.

Authors:  E R Brown; A Stark; I Sosenko; E E Lawson; M E Avery
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

10.  Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor.

Authors:  D Johnson; J Travis
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

View more
  69 in total

Review 1.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  In vivo studies of rat alveolar macrophage [corrected] microviscosity: influence of pulmonary surfactant synthesis stimulation.

Authors:  M Luisetti; M Salmona; E Pozzi; M Genghini; L Spialtini; P Masturzo
Journal:  Lung       Date:  1987       Impact factor: 2.584

Review 3.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

4.  Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury.

Authors:  Hiroshi Hirakawa; Richard A Pierce; Gulbin Bingol-Karakoc; Cagatay Karaaslan; Meiqian Weng; Guo-Ping Shi; Ali Saad; Ekkehard Weber; Thomas J Mariani; Barry Starcher; Steve D Shapiro; Sule Cataltepe
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

5.  Patient-Derived Airway Secretion Dissociation Technique To Isolate and Concentrate Immune Cells Using Closed-Loop Inertial Microfluidics.

Authors:  Hyunryul Ryu; Kyungyong Choi; Yanyan Qu; Taehong Kwon; Janet S Lee; Jongyoon Han
Journal:  Anal Chem       Date:  2017-04-21       Impact factor: 6.986

Review 6.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

7.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

8.  Lipid peroxidation and lung ultrastructural changes in an experimental model of leukocyte-mediated pulmonary injury.

Authors:  E Borrelli; P Giomarelli; O Chiara; A Casini; S Betti; L Sabatini; L Lorenzini; A Grossi
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 9.  Current perspectives on the prevention and management of chronic lung disease in preterm infants.

Authors:  Prakesh S Shah
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  The fate of exogenous surfactant in neonates with respiratory distress syndrome.

Authors:  M Hallman; T A Merritt; K Bry
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.